Page 187 - Read Online

Sobenin et al. Is insulin atherogenic?

Ethics approval 2009;25:491-501.
This study was kept in accordance with the Helsinki 19. American Diabetes Association. (2) Classification and diagnosis of
diabetes. Diabetes Care 2015;38 Suppl:S8-16.
Declaration of 1975 as revised in 1983. It was 20. Sobenin IA, Galitsyna EV, Grechko AV, Orekhov AN. Small dense
approved by the local ethics committee of the Institute and desialylated low density lipoprotein in diabetic patients. Vessel
for Atherosclerosis Research, Skolkovo Innovation Plus 2017;1:29-37.
Center, Moscow, Russia. 21. Tertov VV, Orekhov AN, Ryong LH, Smirnov VN. Intracellular
cholesterol accumulation is accompanied by enhanced proliferative
REFERENCES activity of human aortic intimal cells. Tissue Cell 1988;20:849-54.
22. Adams DO. Macrophages. In: Jakoby WB, Pastan JA, editors.
Methods in Enzymology. New York: Academic Press;1979. p. 494-
1. Yahagi K, Kolodgie FD, Lutter C, Mori H, Romero ME, Finn 506.
AV, Virmani R. Pathology of human coronary and carotid artery 23. Slavina ES, Madanat AYa, Pankov YuA, Syrkin AL, Tertov VV,
atherosclerosis and vascular calcification in diabetes mellitus. Orekhov AN. Diabetes mellitus and atherosclerosis. N Engl J Med
Arterioscler Thromb Vasc Biol 2017;37:191-204. 1987;317:836.
2. Heier M, Margeirsdottir HD, Gaarder M, Stensæth KH, Brunborg 24. Sobenin IA, Tertov VV, Koschinsky T, Bünting CE, Slavina ES,
C, Torjesen PA, Seljeflot I, Hanssen KF, Dahl-Jørgensen K. Soluble Dedov II, Orekhov AN. Modified low density lipoprotein from
RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year diabetic patients causes cholesterol accumulation in human intimal
follow-up study. Cardiovasc Diabetol 2015;14:126. aortic cells. Atherosclerosis 1993;100:41-54.
3. Hunt KJ, Baker NL, Cleary PA, Klein R, Virella G, Lopes-Virella 25. Sobenin IA, Tertov VV, Orekhov AN. Atherogenic modified LDL in
MF; DCCT/EDIC Group of investigators. Longitudinal association diabetes. Diabetes 1996;45 Suppl 3:S35-9.
between endothelial dysfunction, inflammation, and clotting 26. Lyons TJ, Klein RL, Baynes JW, Stevenson HC, Lopes-Virella
biomarkers with subclinical atherosclerosis in type 1 diabetes: an MF. Stimulation of cholesteryl ester synthesis in human monocyte-
evaluation of the DCCT/EDIC cohort. Diabetes Care 2015;38:1281- derived macrophages by low-density lipoproteins from type 1
9. (insulin-dependent) diabetic patients: the influence of non-enzymatic
4. Yoon HJ, Lee YH, Kim SR, Rim TH, Lee EY, Kang ES, Cha BS, glycosylation of low-density lipoproteins. Diabetologia 1987;30:916-
Lee HC, Lee BW. Glycated albumin and the risk of micro- and 23.
macrovascular complications in subjects with type 1 diabetes. 27. Lopes-Virella MF, Virella G. Pathogenic role of modified LDL
Cardiovasc Diabetol 2015;14:53. antibodies and immune complexes in atherosclerosis. J Atheroscler
5. Heier M, Margeirsdottir HD, Brunborg C, Hanssen KF, Dahl- Thromb 2013;20:743-54.
Jørgensen K, Seljeflot I. Inflammation in childhood type 1 diabetes; 28. Stout RW. Insulin and atheroma. 20-yr perspective. Diabetes Care
influence of glycemic control. Atherosclerosis 2015;238:33-7. 1990;13:631-54.
6. Zeadin MG, Petlura CI, Werstuck GH. Molecular mechanisms linking 29. Savage PJ, Saad MF. Insulin and atherosclerosis: villain, accomplice,
diabetes to the accelerated development of atherosclerosis. Can J or innocent bystander? Br Heart J 1993;69:473-5.
Diabetes 2013;37:345-50. 30. Fontbonne AM, Eschwège EM. Insulin and cardiovascular disease.
7. Shah MS, Brownlee M. Molecular and cellular mechanisms of Paris prospective study. Diabetes Care 1991;14:461-9.
cardiovascular disorders in diabetes. Circ Res 2016;118:1808-29. 31. Yosefy C. Hyperglycaemia and its relation to cardiovascular
8. Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med morbidity and mortality: has it been resolved? Acta Diabetol 2003;40
2016;26:364-73. Suppl 2:S380-8.
9. Tune JD, Goodwill AG, Sassoon DJ, Mather KJ. Cardiovascular 32. Stout RW. Insulin stimulation of cholesterol synthesis by arterial
consequences of metabolic syndrome. Transl Res 2017;183:57-70. tissue. Lancet 1970;1:248.
10. Stout RW. Hyperinsulinemia and atherosclerosis. Diabetes 1996;45 33. Wahlqvist ML, Stout RW. The effect of insulin on the incorporation
Suppl 3:S45-6. of sodium (1-14C)-acetate into the lipids of the rat aorta. Diabetologia
11. Gwinup G, Elias AN. Hypothesis: insulin is responsible for the 1972;8:305-6.
vascular complications of diabetes. Med Hypotheses 1991;34:1-6. 34. Stout RW. Diabetes and atherosclerosis--the role of insulin.
12. Bansilal S, Farkouh ME, Fuster V. Role of insulin resistance and Diabetologia 1979;16:141-50.
hyperglycemia in the development of atherosclerosis. Am J Cardiol 35. Sato Y, Shiraishi S, Oshida Y, Ishiguro T, Sakamoto N. Experimental
2007;99:B6-14. atherosclerosis-like lesions induced by hyperinsulinism in Wistar rats.
13. Stout RW. Insulin as a mitogenic factor: role in the pathogenesis of Diabetes 1989;38:91-6.
cardiovascular disease. Am J Med 1991;90:S62-5. 36. Abe H, Bandai A, Makuuchi M, Idezuki Y, Nozawa M, Oka T, Osuga
14. Escudero CA, Herlitz K, Troncoso F, Guevara K, Acurio J, Aguayo J, Watanabe Y, Inaba T, Yamada N. Hyperinsulinaemia accelerates
C, Godoy AS, González M. Pro-angiogenic role of insulin: from accumulation of cholesterol ester in aorta of rats with transplanted
physiology to pathology. Front Physiol 2017;8:204. pancreas. Diabetologia 1996;39:1276-83.
15. Rask-Madsen C, Buonomo E, Li Q, Park K, Clermont AC, 37. Chattopadhyay DP, Martin JM. Effect of insulin on the in vitro
Yerokun O, Rekhter M, King GL. Hyperinsulinemia does not synthesis of sterol and fatty acid by aorta and liver from diabetic rats.
change atherosclerosis development in apolipoprotein E null mice. J Atheroscler Res 1969;10:131-4.
Arterioscler Thromb Vasc Biol 2012;32:1124-31. 38. Chobanian AV, Gerritsen GC, Brecher PI, McCombs L. Aortic
16. Jarrett RJ. Is insulin atherogenic? Diabetologia 1988;31:71-5. glucose metabolism in the diabetic Chinese hamster. Diabetologia
17. Durrington PN. Is insulin atherogenic? Diabet Med 1992;9:597-600. 1974;10 Suppl:589-93.
18. Radermecker RP, Renard E, Scheen AJ.Circulating insulin antibodies: 39. Christensen S, Jensen J. Uptake of labelled cholesterol from plasma
influence of continuous subcutaneous or intraperitoneal insulin by aortic intima-media in control and insulin-injected rabbits. J
infusion, and impact on glucose control. Diabetes Metab Res Rev Atheroscler Res 1965;5:258-9.

180 Vessel Plus ¦ Volume 1 ¦ December 28, 2017